Nautilus Biotechnology, Inc. (NAUT)
2.04
+0.01
(+0.49%)
USD |
NASDAQ |
Dec 09, 16:00
2.04
0.00 (0.00%)
Pre-Market: 20:00
Nautilus Biotechnology EPS Diluted (Quarterly): -0.1075 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Prelude Therapeutics, Inc. | -0.2591 |
| Protalix Biotherapeutics, Inc. | 0.0291 |
| Genprex, Inc. | -4.996 |
| GoodRx Holdings, Inc. | 0.0032 |
| Pelthos Therapeutics, Inc. | -5.304 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -13.57M |
| Total Expenses (Quarterly) | 13.57M |
| Enterprise Value | 153.24M |
| Earnings Yield | -24.42% |
| Normalized Earnings Yield | -24.42 |